Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection

Clinical trial NCT05109611 · TERMINATED

Trial details

NCT number: NCT05109611
Sponsor: Sanotize Research and Development corp.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

SARS-CoV-2 Infection

Start date: 2021-11-20
Primary completion: 2024-01-30
Enrollment: 1389

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.